Real-time enrollment status for this fibrostenotic crohn's disease clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 2:11 AM UTC
| NCT Number | NCT07683325 |
| Recruiting Status | Recruiting |
| Condition | Fibrostenotic Crohn's Disease |
| Phase | PHASE2 |
| Target Enrollment | 320 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Agomab Spain S.L.U. |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 17, 2026: Clinical trial NCT07683325 is currently recruiting participants. This phase2 study for fibrostenotic crohn's disease is actively seeking new participants at 4 locations across the United States. The study is sponsored by Agomab Spain S.L.U.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07683325 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07683325 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.